Description

(1Ar,7R,11Ar)-1A,2,3,7,11,11A-Hexahydro-8,11A-Dimethyl-5H-7,4-Methenofuro[3,2-C]Oxireno[F]Oxacycloundecin-5-One CAS NO 15004-50-9 is a complex, high-purity organic compound characterized by its unique fused polycyclic structure containing oxirane and furan moieties. This compound is valued as a critical advanced pharmaceutical intermediate and a versatile building block in sophisticated organic synthesis. It is primarily sought after by research institutions and manufacturers in the pharmaceutical and fine chemical sectors for developing novel active ingredients and complex molecular architectures.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of complex drug candidates, particularly those with intricate polycyclic frameworks.
• Organic Synthesis Building Block: Utilized in advanced research and development for constructing novel heterocyclic compounds and natural product analogs.
• Medicinal Chemistry Research: Employed in structure-activity relationship (SAR) studies and the discovery of new therapeutic agents.
• Chemical Reference Standard: Used as a high-purity standard for analytical method development, validation, and quality control in laboratories.
• Process Chemistry Development: Acts as a model compound for developing and optimizing scalable synthetic routes in fine chemical production.

Basic Information

Product Name	(1Ar,7R,11Ar)-1A,2,3,7,11,11A-Hexahydro-8,11A-Dimethyl-5H-7,4-Methenofuro[3,2-C]Oxireno[F]Oxacycloundecin-5-One
CAS No.	15004-50-9
Molecular Formula	C₁₇H₂₀O₄
Molecular Weight	288.34 g/mol
Synonyms	7,4-Methenofuro[3,2-c]oxireno[f]oxacycloundecin-5-one, 1a,2,3,7,11,11a-hexahydro-8,11a-dimethyl-, (1aR,7R,11aR)-; (-)-Crotepoxide; Crotepoxide; CAS 15004-50-9; NSC 125066; 1a,2,3,7,11,11a-Hexahydro-8,11a-dimethyl-5H-7,4-methenofuro[3,2-c]oxireno[f]oxacycloundecin-5-one
EINECS	Contact for details

Quality Control

Every batch of this high-value intermediate is produced and tested under stringent quality management systems. We provide comprehensive Certificates of Analysis (COA) detailing purity, identity, and impurity profiles to ensure it meets the exacting standards required for pharmaceutical research and development. Our quality commitment aligns with cGMP principles where applicable, ensuring traceability, consistency, and reliability for our global B2B partners.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to exclude moisture. For long-term storage, consider using desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.